2-169259078-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004525.3(LRP2):​c.2460A>G​(p.Thr820Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.497 in 1,612,380 control chromosomes in the GnomAD database, including 206,412 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 23672 hom., cov: 30)
Exomes 𝑓: 0.49 ( 182740 hom. )

Consequence

LRP2
NM_004525.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.419

Publications

31 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-169259078-T-C is Benign according to our data. Variant chr2-169259078-T-C is described in ClinVar as [Benign]. Clinvar id is 129510.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.419 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.732 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP2NM_004525.3 linkc.2460A>G p.Thr820Thr synonymous_variant Exon 17 of 79 ENST00000649046.1 NP_004516.2 P98164Q7Z5C0Q7Z5C1
LRP2XM_011511183.4 linkc.2460A>G p.Thr820Thr synonymous_variant Exon 17 of 78 XP_011509485.1
LRP2XM_047444340.1 linkc.1536A>G p.Thr512Thr synonymous_variant Exon 17 of 79 XP_047300296.1
LRP2XM_011511184.3 linkc.171A>G p.Thr57Thr synonymous_variant Exon 2 of 64 XP_011509486.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP2ENST00000649046.1 linkc.2460A>G p.Thr820Thr synonymous_variant Exon 17 of 79 NM_004525.3 ENSP00000496870.1 P98164
LRP2ENST00000443831.1 linkc.2049A>G p.Thr683Thr synonymous_variant Exon 15 of 23 2 ENSP00000409813.1 E9PC35

Frequencies

GnomAD3 genomes
AF:
0.549
AC:
83113
AN:
151526
Hom.:
23636
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.687
Gnomad AMI
AF:
0.440
Gnomad AMR
AF:
0.608
Gnomad ASJ
AF:
0.512
Gnomad EAS
AF:
0.478
Gnomad SAS
AF:
0.755
Gnomad FIN
AF:
0.387
Gnomad MID
AF:
0.589
Gnomad NFE
AF:
0.470
Gnomad OTH
AF:
0.550
GnomAD2 exomes
AF:
0.546
AC:
137151
AN:
251078
AF XY:
0.548
show subpopulations
Gnomad AFR exome
AF:
0.694
Gnomad AMR exome
AF:
0.686
Gnomad ASJ exome
AF:
0.543
Gnomad EAS exome
AF:
0.476
Gnomad FIN exome
AF:
0.391
Gnomad NFE exome
AF:
0.470
Gnomad OTH exome
AF:
0.515
GnomAD4 exome
AF:
0.492
AC:
718665
AN:
1460736
Hom.:
182740
Cov.:
44
AF XY:
0.499
AC XY:
362906
AN XY:
726712
show subpopulations
African (AFR)
AF:
0.691
AC:
23105
AN:
33438
American (AMR)
AF:
0.677
AC:
30220
AN:
44636
Ashkenazi Jewish (ASJ)
AF:
0.526
AC:
13724
AN:
26108
East Asian (EAS)
AF:
0.458
AC:
18170
AN:
39682
South Asian (SAS)
AF:
0.747
AC:
64389
AN:
86240
European-Finnish (FIN)
AF:
0.394
AC:
21038
AN:
53414
Middle Eastern (MID)
AF:
0.553
AC:
3184
AN:
5762
European-Non Finnish (NFE)
AF:
0.463
AC:
513971
AN:
1111122
Other (OTH)
AF:
0.512
AC:
30864
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
18934
37868
56803
75737
94671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15496
30992
46488
61984
77480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.549
AC:
83203
AN:
151644
Hom.:
23672
Cov.:
30
AF XY:
0.550
AC XY:
40714
AN XY:
74086
show subpopulations
African (AFR)
AF:
0.687
AC:
28415
AN:
41348
American (AMR)
AF:
0.608
AC:
9257
AN:
15214
Ashkenazi Jewish (ASJ)
AF:
0.512
AC:
1770
AN:
3458
East Asian (EAS)
AF:
0.478
AC:
2445
AN:
5116
South Asian (SAS)
AF:
0.752
AC:
3612
AN:
4800
European-Finnish (FIN)
AF:
0.387
AC:
4077
AN:
10530
Middle Eastern (MID)
AF:
0.588
AC:
173
AN:
294
European-Non Finnish (NFE)
AF:
0.470
AC:
31884
AN:
67864
Other (OTH)
AF:
0.555
AC:
1170
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1762
3524
5285
7047
8809
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
716
1432
2148
2864
3580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.502
Hom.:
38830
Bravo
AF:
0.567
Asia WGS
AF:
0.650
AC:
2260
AN:
3478
EpiCase
AF:
0.479
EpiControl
AF:
0.481

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Donnai-Barrow syndrome Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.1
DANN
Benign
0.22
PhyloP100
0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2241190; hg19: chr2-170115588; COSMIC: COSV55546459; API